Jonathan Wadsley Alan Christie Roopinder Gillmore Amy Trinh Rachel Greig
10.7573/dic.2023-5-5
Drugs Context
2023 Aug 14;12:2023-5-5.
fgfr2 fusion cholangiocarcinoma metastatic disease pemigatinib
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/37602357/
Case Reports
PMC10435267
37602357
Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases
2023